Supernus Pharmaceuticals, Inc. (SUPN)
51.30
-0.35
(-0.68%)
USD |
NASDAQ |
Feb 09, 16:00
51.60
+0.30
(+0.58%)
Pre-Market: 08:05
Supernus Pharmaceuticals EPS Diluted (Quarterly) : -0.7978 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Krystal Biotech, Inc. | 2.660 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.12M |
| Revenue (Quarterly) | 192.10M |
| Total Expenses (Quarterly) | 237.22M |
| Enterprise Value | 2.703B |
| Gross Profit Margin (Quarterly) | 77.20% |
| Profit Margin (Quarterly) | -23.49% |
| Earnings Yield | -0.66% |
| Normalized Earnings Yield | -0.5653 |